MedPage Today - Common BP Med May Lower Risk of Dementia
Beta-blockers seemed to reduce the risk of dementia and Alzheimer's disease in older Japanese-American men, according to a study that will be reported at the American Academy of Neurology. The study showed "a congruent amelioration of cognitive decline or impairment associated with beta-blocker use," the authors concluded. However, the relationship may not be causal, noted Mary Sano, PhD, of The Mount Sinai Medical Center. "I think we have to recognize that it's possible that people who needed only one drug – the beta-blockers – may have had less disease to begin with," said Dr. Sano. "They may look like they're better not because of the drug, but because of a less severe underlying condition."
- Dr. Mary Sano, Associate Dean for Clinical Research, Professor, Psychiatry, Director of the Alzheimer's Disease Research, Icahn School of Medicine at Mount Sinai
Learn and watch more